/PRNewswire/ Cannabis genetics company Phylos®, along with People Science, a direct-to-consumer scientific research and technology company, has conducted an.
Until recently, most commercial cannabis growers relied on clones, but seed-based production is on the rise. Phylos Bioscience is exploring the potential of THCV.
Organigram Holdings Inc. (OGI, OGI.TO) announced that Phylos Bioscience Inc., a U.S. cannabis genetics company and provider of production ready seeds, has achieved the first milestone under the loan agreement entered into in May 2023.
Phylos is a recognized leader in seed genetics with a growing IP portfolio including the highest potency THCV cultivars available
Organigram will launch new products in Canada containing THCV, a. | May 25, 2023
/PRNewswire/ Modern crop science company Phylos®, is providing a long-awaited solution for commercial growers looking for uniformity, input reduction, and.